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ABSTRACT 
 
Aims and objectives: Intracavitary radiotherapy (ICR) is a form of brachytherapy used in treatment of early or 
locally confined cervical cancer. This study was undertaken to study the comparison of combination of intravenous 
Inj. magnesium sulphate and Inj. propofol with Inj. fentanyl citrate and Inj.propofol in patients undergoing 
intracavitary brachytherapy for locally confined carcinoma of cervix under total intravenous anesthesia. Material 
and method: Fifty patients belonging to ASA I and ASA II were randomly divided into two groups. Group M 
received i.v magnesium sulphate 30mg/kg, ten minutes before procedure and group F received i.v fentanyl citrate 
1µg/kg ten minutes before procedure. Group M received Magnesium sulphate 10mg/kg/hr by continuous i.v infusion 
during the procedure. Group F received same amount of isotonic saline. For induction injection propofol, 1-2mg/kg 
was given intravenously.  Anaesthesia was maintained with i.v. propofol 1mg/kg as and when required in 
incremental doses. We monitored pulse, blood pressure, ECG and SPO2 at preprocedure, during procedure, at the 
end of procedure, 5mins, 10 mins and 30 mins in recovery room. Patients were observed for nausea, vomiting, 
sedation, shivering and visual analogue scale score for measurement of severity of pain. We observed total amount 
of propofol required during the procedure. Results: The total amount of propofol required in group 
M(130±19.09mg) was less as compared to group F (172.8±29.09mg).That was statistically significant(P=0.0187). 
Both the groups were similar in hemodynamic stability in terms of systolic and diastolic blood pressures, mean 
arterial pressure and heart rate throughout the procedure. Postoperative visual analogue scale score and satisfaction 
score were similar in both groups. Sedation score was higher in group F as compared to group M (P 
<0.05).Incidence of nausea, vomiting, shivering were less in group M as compared to group F. Conclusion: 
Preoperative administration of i.v. magnesium sulphate reduces propofol requirement and reduces incidence of 
nausea, vomiting, shivering and sedation in post-operative period. Hence magnesium sulphate can be used in place 
of fentanyl citrate, where fentanyl citrate is contraindicated. 
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Introduction 
 
 
Intracavitary radiotherapy (ICR) is a procedure used as 
a part of radiation therapy for treatment of early or 
locally confined cervical cancer. The pain is mainly 
due to cervical dilatation and placement of radiation 
applantors, which were kept in situ till the completion 
of radiotherapy session. It has been studied that post  
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injury pain hypersensitivity results via central 
mechanism. Pre-emptive analgesia is defined as an 
antinoceptive treatment that prevents establishment of 
altered central processing of afferent input from injury. 
Proper pain relief and hemodynamic stability is of 
prime concern for anesthesiologist for patient 
management in intraoperative and postoperative 
period. Different therapies have been listed in pre-
emptive trails like non steroidal anti inflammatory 
drugs(NSAIDS), intravenous opioids, intravenous 
ketamine, peripheral local anesthetics, caudal and 
epidural analgesia, dextromethorphan and 
gabapentin[1]. Magnesium Sulphate is 4th most 
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abundant cation in body and 2nd most abundant 
intracellular cation.[2,3] It acts as a natural calcium 
uptake in cell. It is an inorganic ion used in treatment 
of eclampsia and pre-eclampsia, hypokalemia, 
postoperative acute pain control and hemodynamic 
stability during intubation.[4-6] It has become an 
important drug for anesthesiologist due to its property 
to prevent pain by acting as N-methyl-D-
aspartate(NMDA) receptor antagonist. Magnesium 
Sulphate is a non-competitive NMDA receptor 
antagonist with antinoceptive effects. NMDA receptor 
antagonist are best administered before the generation 
of noxious stimuli in order to prevent central 
sensitization.[7]  
The action of propofol is to promote the function of a 
subunit of Gama-aminobuteric acid (GABA) through 
activation of the chloride channel and there by enhance 
the inhibitory synaptic transmission.[8] Propofol also 
inhibits the NMDA subtype of glutamate receptor. 
Inhibition of NMDA mediated excitatory neuro-
transmission may contribute to the anesthetic, amnesic 
and anticonvulsant properties of propofol. Therefore, 
the aforementioned action of mechanism suggest that 
magnesium sulphate when co-administered with 
propofol, potentiates anesthetic effect and NMDA 
antagonism of propofol.[9] 
 Fentanyl citrate belongs to opioid group of 
analgesia. It acts on opioid receptor and therefore when 
given pre-emptively gives hemodynamic stability and 
analgesia. At the same time being an opioid it has its 
adverse effects like respiratory depression, nausea, 
vomiting, itching etc. Fentanyl plays an important role 
in balanced general anesthesia by virtue of meeting all 
aspects of balanced anaesthesia like narcosis, analgesia 
and attenuation of stress response. But apart from 
associated respiratory depression, chest rigidity and 
post-operative nausea vomiting(PONV), its 
procurement in India is difficult due to rigid narcotic 
regulation.[10]This controlled double blind study was 
designed to assess and compare the effect of 
magnesium sulphate and fentanyl on hemodynamics 
during procedure and after procedure, propofol 
consumption and post-operative recovery when used as 
adjuvant agent. 
 
Materials & methods 
 
After hospital ethics committee approval a total fifty 
female patients aged between 40-60 years and 
belonging to ASA grade I and II were taken for this 
study after taking their written consent. Patients with 
renal or hepatic dysfunction, neurological disorder, 
varying degree of heart block, hypertension, myopathy, 
diabetes, drugs or alcohol consumption, patients treated 
with calcium channel blockers or magnesium 
containing antacids were excluded. 
The patients were randomized to receive either 
magnesium sulphate 30mg/kg i.v. (Group M) or 
fentanyl citrate 1mcg/kg i.v. stat (Group F) ten minutes 
before procedure over ten minutes. The purpose, 
protocol of study and use of visual analogue scale score 
( 0-10; 0-no pain, 1-3 mild pain, 4-6 moderate pain, 7-
10 severe pain ) were explained to the patients. The 
drugs were prepared by the anesthetist involved in the 
study and were given by the anesthetist who did not 
participate in the study. The study drug was given as 
bolus dose ten minutes before the procedure over ten 
minutes. Inj. Propofol 1-2 mg/kg and inj glycopyrolate 
0.02mg were given intravenously for induction and 
anaesthesia was maintained with inj. propofol 1mg/kg 
i.v. in incremental doses. Inj Magnesium Sulfate 
10mg/kg/hr infusion was given throughout procedure 
to the patients of group M and saline infusion was 
given to the patients of group F. We monitored pulse 
rate, systolic and diastolic blood pressure, ECG, SPO2 
throughout the procedure. Pulse rate, systolic blood 
pressure, diastolic blood-pressure and mean arterial 
pressure were observed and recorded at pre procedure, 
during procedure every 5min till end of procedure, 
every 5min after the procedure till applantors are in situ 
and thereafter 30 mins and 1 hour in recovery room. 
   Pain was evaluated using visual analogue scale score 
(0-no pain, 1-3 mild pain, 4-6 moderate pain, 7-10 
severe pain) at the end of procedure, during the 
radiation period and 30 mins and 1 hour after 
completion of radiation. The total amount of inj. 
Propofol required was observed in each group. 
Sedation score was observed using four point rating 
scale (0-fully awake, 1-slightly drowsy, 2-asleep but 
easily arousable, 3-asleep but not arousable). 
Satisfaction score was asked after procedure (1-very 
unsatisfactory, 2-unsatisfactory, 3-satisfactory, 4-good, 
5-excellent). All patients were kept in recovery room 
after completion of radiation. 
 
 
Statistical analysis 
 
All data were compiled and were expressed as mean± 
SD. Data were analysed using student t test. Mean 
values were compared using analysis of variance 
(ANOVA) / paired t test. P value of <0.05 was 
considered significant. 
 
Results 
 
The demographic profile (age, weight), preoperative 
hemodynamic variables and duration of procedure 
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were comparable in both the groups as shown in table 
1. The hemodynamic parameters as pulse rate, mean 
arterial pressure were similar in both the groups and 
were statistically insignificant at each time interval as 
shown in table 2 and 3.The consumption of propofol 
during procedure was calculated in each group. Group 
M required 130 ±19.09 mg of propofol. Whereas group 
F required 172.8±29.1 mg, which was less in Group M 
and statistically significant (P< 0.0187) (table 4). There 
was no statistically significant difference between the 
groups in VAS score at each time interval (table 5). 
The incidence of nausea, vomiting and shivering were 
more in Group F as compared to Group M. Sedation 
score was higher in Group F (1.72±1.17) as compared 
to Group M (0.68±0.94), (P<0.0017). Mean Serum Mg 
level at one hour after the procedure in patients of 
group M was 1.7mg/dl(table 6). 
 
Discussion  
 
Intense or repeated noxious stimulation causes release 
of excitatory amino acids such as glutamate and 
aspartate in dorsal horn. These amino acids are 
mediated by NMDA and non-NMDA receptors. 
Activation of NMDA receptor leads to calcium entry 
into the cell and initiates a series of central 
sensitization. This central sensitization has a main role 
in pain perception and is considered to be one of the 
mechanisms implicated in the persistence of 
postoperative pain. NMDA antagonists have potential 
to prevent the induction and maintenance of central 
sensitization. Magnesium acts as an antagonist at 
NMDA receptor and its associated channel. Therefore 
magnesium could modulate postoperative pain by 
preventing nociception associated central sensitization 
by blocking NMDA receptor calcium inophore.[11] 
Our study has shown that infusion of Magnesium 
sulphate (10mg/kg) ten minutes prior to induction has 
decreased the overall consumption of Propofol Citrate. 
There are few studies which used Magnesium Sulphate 
as bolus and during the procedure as continuous 
infusion. A study done by A. Altan et al. with 60 pts 
divided into two groups. Group M received 30mg/kg of 
magnesium sulphate as a bolus before induction and 
10mg/kg/hr by infusion. Control group received same 
volume of isotonic saline. This study revealed that 
there was rapid induction of anesthesia in patients 
receiving magnesium sulphate. There was no statistical 
difference between both the groups with respect to 
hemodynamic parameters. Consumption of injection 
Propofol was lower in magnesium sulphate receiving 
group. [12] This is in concurrence with our study. In 
our study there was significant difference in 
consumption of propofol between two groups. 
Adequate bolus and infusion doses of Magnesium 
sulphate are important for effective analgesia. [11] 
Magnesium causes a dose-dependent negative effect 
and a peripheral vasodilatation. Minor side effect of 
parenteral magnesium such as flushing, nausea and 
headache are expected at serum magnesium level more 
than 2mmol/l. Potential life threatening complication 
primarily involved in cardiovascular and neurovascular 
system can occur when serum Magnesium 
concentration exceeds 5mmol/l[5]. In our patients it 
never exceeded 2mmol/l. Another study done by J.H 
Ryu et  al. with i.v magnesium sulphate 50mg/kg as 
bolus followed by infusion at 15mg/kg/hr. Control 
group received equal amount of isotonic saline. This 
study concluded that total amount of propofol and 
ramifentanyl administered were similar in both groups, 
mean arterial pressure just after intubation and post-
operative period was significantly lower in Group M. 
Postoperative VAS, analgesic consumption, incidence 
of nausea vomiting and shivering were significantly 
low in Group M (P<0.05).[7]A study done by Shashi 
Kiran et. al. in which magnesium sulphate receiving 
Group received 50mg/kg magnesium sulphate in 250ml 
isotonic saline 30 mins prior to procedure. Control 
group received equal volume of isotonic saline. Pain 
was significantly lower in magnesium sulphate group. 
This study concluded that rescue analgesia requirement 
postoperatively was significantly lower in group 
M.[13] We did not found significant difference in VAS 
score in our study. 
 
Table 1: Demographic and clinical characterization 
Characteristics GROUP M GROUP F 
Age (years) 43.2±8.6 45.1±7.6 
Weight (Kg) 45.4±4.4 43.6±5.1 
No. of  Patients 25 25 
Duration of procedure (min.) 9.8±0.3 10.1±0.1 
Duration of applanators kept in situ (min.) 10±1.1 9.9±1.2 
Data are presented in mean ± standard deviation. Both the groups are similar for all the parameters. 
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Table 2: Comparison of pulse rate 
Time  Group M Group F P-Value 
Pre induction 90.48±10.23 87.64±12.23 0.38 
Pre procedure 95.25±11.48 92.64±11.21 0.42 
5 min 87.28±10.41 85.48±9.87 0.5 
10 min 90.52±10.28 88.2±10.31 0.4 
End of procedure 95.25±11.48 92.64+/-11.21 0.42 
30 min 88.32±9.72 86.24±10.08 0.45 
1 hour 88.22±9.78 86.63±10.66  0.58 
 
Data are presented in mean ± standard deviation. P<0.05 significant. 
 
Table 3: Comparison of mean arterial pressure in mm of Hg 
Time  Group M Group F P Value 
Pre induction 97 ± 5.93 95.04 ± 6.18 0.25 
Pre procedure 102.36 ± 5.66 99.08 ± 6.03 0.053 
5 min 94.88± 4.55 92.65 ± 5.79 0.136 
10 min 97.16 ± 4.45 94.58 ± 5.52 0.017 
End of procedure 93.58 ± 3.95 90.92 ± 5.83 0.063 
30 min 93.52 ± 4.16 90.84 ± 5.69 0.055 
1 hour 93.72 ± 4.14 90.96 ± 5.85 0.054 
Data are presented in mean ± standard deviation. P<0.05 Significant. 
Table 4: Comparison of Propofol consumption 
Variables Group M Group F P Value 
Total amount of Propofol used 130±19.09 172±29.1 0.0187 
Data are presented in mean ± standard deviation. P<0.05 Significant. 
Table 5: Comparison of Visual Analog Scale score 
Time Group M Group F P Value 
End of procedure 5.28 ± 1.67 5.2 ± 1.8 0.112 
After 30 min 2.44 ± 0.3 27 ± 0.2 0.182 
After 1 hour No pain No pain  
Data are presented in mean ± standard deviation. P<0.05 Significant. Vas score was similar in both the groups 
Table 6: Comparison of satisfactory score, sedation score, incidence of nausea, vomiting and shivering 
Variable Group M Group F P Value 
Satisfaction score 4.04  0.97 3.9  3.92 0.66 
Sedation score 0.68  0.94 1.72  1.17 0.001 
Incidence of nausea 4%  16%  
Incidence of vomiting None 24%  
Incidence of shivering None 4%  
Data are presented in mean ± standard deviation. P<0.05 Significant. Incidence presented in percentage of patients. 
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Conclusion 
 
Preprocedure administration of i.v Magnesium 
sulphate(30mg/kg) reduces propofol requirement and 
reduces incidence of nausea, vomiting, shivering and 
sedation in postoperative period. . Hence magnesium 
sulphate can be used in place of fentanyl citrate, where 
fentanyl citrate is contraindicated. 
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